Why Does Tadalafil Cause Back Pain?

Tadalafil causes back pain in roughly one out of every ten people who take it, making it one of the drug’s most distinctive side effects. The leading explanation centers on tadalafil’s tendency to inhibit not just its intended target enzyme but also a closely related one found in skeletal muscle, though researchers have not been able to confirm this with direct tissue evidence. The pain is almost always mild, self-limiting, and manageable, but it catches people off guard because back pain is not something you expect from an erectile dysfunction pill.

How Common the Back Pain Actually Is

An analysis pooling ten placebo-controlled clinical trials with over 1,800 participants found that back pain or muscle aches occurred in about 8 to 9 percent of men taking tadalafil, compared to roughly 4 percent of those on placebo.¹ That gap tells you the drug is genuinely responsible for some of those cases, not all of them. Plenty of people get back pain for reasons unrelated to any medication, and the placebo rate reflects that background noise.

In longer-term safety data spanning 18 to 24 months, back pain showed up in about 8 percent of users, and fewer than 1 percent of participants stopped taking the drug because of any single side effect.² In clinical overviews, headache and stomach upset consistently rank as the most frequent complaints, with back pain and muscle aches trailing in third or fourth place.³ So while back pain is a real and recognized side effect, it is not the most common one, and most people who experience it do not find it severe enough to stop treatment.

The PDE11 Hypothesis

Tadalafil works by blocking an enzyme called PDE5, which is the same basic mechanism used by sildenafil and vardenafil. But enzymes come in families, and PDE5 has close molecular relatives. One of those relatives, PDE11, happens to be found in skeletal muscle, the prostate, and several other tissues.⁴ Tadalafil is considered highly selective for PDE5, but it also potently inhibits PDE11, an enzyme whose normal role in the body is still not well understood.⁵

Here is where it gets interesting. When researchers measured how selective each of the three major drugs in this class is for PDE5 versus PDE11, tadalafil came in at about 40-fold selectivity. Vardenafil showed about 9,300-fold selectivity, and sildenafil about 1,000-fold.⁶ In plain terms, tadalafil is much more likely to spill over onto PDE11 than its competitors are. Because PDE11 is present in skeletal muscle, the thinking is that tadalafil’s cross-reactivity with this enzyme triggers the muscle aches and back pain that patients report.⁷

That said, the same biochemical study that measured these selectivities concluded that even tadalafil’s 40-fold gap was likely large enough to avoid clinically meaningful PDE11 cross-reaction at normal therapeutic doses.⁶ So the PDE11 story is compelling but not airtight. It is the best hypothesis researchers have, and it fits the pattern of the symptoms, but direct proof is still missing.

What Researchers Have Ruled Out

If tadalafil were genuinely damaging muscle tissue, you would expect to see markers of inflammation or muscle breakdown in blood tests. A prospective study in healthy volunteers specifically looked for these markers and found nothing substantial. Researchers also performed imaging scans of the lower back and gluteal muscles using PET and MRI, looking for signs of myositis, and came up empty.¹ The kidneys were checked too, since changes in renal blood flow could theoretically cause referred back pain, but renal plasma flow was not affected.

This is actually reassuring. The back pain from tadalafil does not appear to involve real tissue damage. It seems to be a functional effect, meaning something is producing the sensation of pain without any underlying injury that shows up on scans or lab work. The investigators who ran this study concluded that the pain appears to be self-limiting and represents a general consequence of PDE5 inhibition rather than something specific to tadalafil’s chemistry.¹ That conclusion might sound like it contradicts the PDE11 story, and in a way it does. The honest answer is that the mechanism remains officially unknown despite the PDE11 hypothesis being widely cited.

Why Tadalafil More Than Other ED Drugs

People taking sildenafil or vardenafil occasionally report back pain too, but it is far less common and almost never highlighted in their side-effect profiles. Two factors set tadalafil apart beyond the PDE11 selectivity gap already described.

The first is duration. Tadalafil has the longest half-life of any drug in its class, which is the reason it is marketed as the “weekend pill.”⁸ A longer half-life means the drug stays active in your bloodstream for much longer. While that extended window is a selling point for sexual function, it also means that any off-target effects on muscle enzymes have more time to accumulate and be felt.

The second factor is side-effect duration itself. In a comparison study, the average duration of side effects with tadalafil was about 15 hours, versus roughly 4 hours for sildenafil and about 8 hours for vardenafil. About 30 percent of men taking tadalafil experienced side effects lasting more than 12 hours.⁹ So even if all three drugs could theoretically cause some back discomfort through PDE5 inhibition, tadalafil gives the effect a much longer runway to become noticeable and bothersome.

What the Pain Typically Feels Like

People who experience tadalafil-related back pain typically describe a dull, achy sensation in the lower back, sometimes extending into the upper thighs or buttocks. It usually shows up 12 to 24 hours after taking the pill, which is later than headache or flushing and catches many users off guard. If you wake up with unexplained lower back stiffness the morning after taking tadalafil, this is likely the explanation.

The pain is almost always mild to moderate. In the pooled analysis of clinical trials, only about 0.3 to 0.7 percent of participants found the back pain severe enough to stop taking the drug.¹ For the vast majority, it resolves on its own within a day or two without any treatment. The pattern tends to be most pronounced after the first few doses and may diminish over time as your body adjusts, though this is not guaranteed.

Managing or Preventing the Pain

If you experience back pain from tadalafil and want to keep taking it, the straightforward approach is over-the-counter pain relief. Standard anti-inflammatory medications taken around the time you expect the pain to start can blunt or eliminate the discomfort for most people.

One clinical study took a more systematic approach. Researchers identified patients who had developed back pain on tadalafil, then reintroduced the drug alongside a combination of an anti-inflammatory, a muscle relaxant, and paracetamol for the first three days. Among the 76 patients who went through this rechallenge protocol, none of them developed back pain or muscle aches again, and they were able to continue taking tadalafil afterward.¹⁰ This was a small study and the protocol involved prescription-strength medications, so it is not something to try on your own. But it does suggest that a short course of supportive medication at the start can break the pattern for many people.

There are a few practical strategies worth considering before reaching for pills:

Timing: If you take tadalafil on-demand rather than daily, taking it earlier in the evening and staying well-hydrated may reduce how noticeable the back pain is by the time it peaks.
Dose adjustment: Since the pooled trial data showed similar incidence rates at 10 mg and 20 mg, lowering the dose may not always help, but it is worth discussing with your prescriber if back pain is a persistent issue.
Gentle stretching: Light movement or stretching of the lower back and hip flexors around the expected onset window may ease discomfort, given that the pain seems to be functional rather than caused by tissue injury.

Daily Low-Dose Versus On-Demand Dosing

Tadalafil is available in two dosing patterns: higher doses taken as needed before sexual activity, and a lower daily dose (usually 2.5 or 5 mg) taken every day. A question that comes up frequently is whether daily dosing produces more or less back pain than occasional use.

The clinical trial data on back pain was largely gathered from on-demand dosing studies at 10 and 20 mg. Daily low-dose tadalafil delivers a smaller amount of the drug at any given moment, which means the peak concentration in your blood is lower. In theory, this could reduce the intensity of off-target enzyme effects. Many prescribers report anecdotally that patients on daily low-dose tadalafil experience fewer musculoskeletal complaints, though the back pain can still occur. If you are taking tadalafil primarily for erectile dysfunction and back pain is a recurring nuisance, switching to the daily regimen is a reasonable conversation to have with your doctor.

When Back Pain Is Not From Tadalafil

It is worth remembering that the placebo rate of back pain in the clinical trials was about 4 percent.¹ Back pain is extremely common in the general population, and starting a new medication creates a natural tendency to attribute any new symptom to the drug. If your back pain is one-sided, shooting down a leg, accompanied by numbness or tingling, persistent for more than a few days, or getting worse rather than better, those are signs that something else is going on. Tadalafil-related back pain is bilateral, dull, centered in the lower back, and resolves within 48 hours at most.

People with pre-existing spinal conditions sometimes worry that tadalafil will aggravate their underlying problem. The imaging and lab evidence described earlier suggests it does not cause structural damage, so there is no strong reason to think it would worsen a disc herniation or spinal stenosis. That said, if you already live with chronic back pain, layering tadalafil-related discomfort on top of it could make your symptoms harder to interpret. Keep track of timing. If the pain reliably appears a day after taking the pill and disappears on its own, the drug is the likely culprit.

The Vascular Angle

Because tadalafil is fundamentally a blood vessel relaxer, some researchers have explored whether changes in blood flow to the muscles or spine could explain the pain. One randomized trial looked at tadalafil’s effect on blood flow and pain in patients with a chronic pain condition and found that tadalafil actually reduced pain intensity by about 15 percent compared to placebo in that context.¹¹ That finding runs in the opposite direction from what you would expect if vascular changes were causing the back pain. If anything, improved blood flow from PDE5 inhibition should reduce pain, not increase it.

This is one reason the PDE11 hypothesis holds more weight than a simple vascular explanation. The pain is probably not caused by blood vessels dilating in the back. Something more specific to muscle cell signaling seems to be at play, even if no one has been able to photograph it on a scan.

Why the Uncertainty Persists

It might seem odd that a drug taken by millions of people worldwide still does not have a clearly proven mechanism for one of its most characteristic side effects. Part of the reason is that the back pain is mild and self-limiting. It does not cause lasting harm, it does not send people to the hospital, and it rarely makes them stop treatment. From a pharmaceutical research standpoint, that makes it a low priority for further investigation. The money and effort go toward understanding serious adverse events, not annoying ones.

There is also a practical challenge. To truly prove the PDE11 mechanism, you would need to show that selectively blocking PDE11 in muscle tissue causes pain, or that a version of tadalafil engineered to avoid PDE11 eliminates the back pain. Neither experiment is easy to run in humans. Some medicinal chemistry research has focused on developing tadalafil-like compounds with better selectivity for PDE5 over PDE11, partly with the goal of shedding the back pain side effect.⁷ If one of those compounds eventually makes it to clinical trials and the back pain disappears, that would be strong indirect evidence for the PDE11 theory. For now, the hypothesis remains the best available explanation but not a proven fact.

Tadalafil for Non-ED Uses

Tadalafil is not only prescribed for erectile dysfunction. It is also approved for pulmonary arterial hypertension and for benign prostatic hyperplasia, the enlarged-prostate condition that causes urinary symptoms in older men. In all of these uses, the drug works the same way and has the same side-effect profile. If you are taking tadalafil for your prostate or for a lung condition rather than for sexual function, the back pain phenomenon applies equally. The dose used for pulmonary hypertension is typically higher than the ED dose, which could in theory increase the likelihood, though the published data on back pain incidence comes primarily from the ED trials.

One practical note for people taking daily tadalafil for prostate symptoms: because the daily dose is lower (usually 5 mg), the incidence of bothersome back pain tends to be lower as well. But it is not zero, and if you develop unexplained lower back aches after starting the medication, the drug is a plausible explanation even at that dose.

1
PubMed. A three-part study to investigate the incidence and potential etiologies of tadalafil-associated back pain or myalgia
2
PubMed. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction
3
PubMed Central. Tadalafil in the treatment of erectile dysfunction; an overview of the clinical evidence
4
PubMed Central. Functional characteristics and research trends of PDE11A in human diseases (Review)
5
International Journal of Impotence Research. Potency, selectivity, and consequences of nonselectivity of PDE inhibition
6
International Journal of Impotence Research. High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients
7
PubMed Central. Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development
8
PubMed. PDE5 inhibitors: considerations for preference and long-term adherence
9
PubMed. Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors
10
Journal of Evolution of Medical and Dental Sciences. PREVENTION OF TADALAFIL INDUCED BACKACHE IN ERECTILE DYSFUNCTION PATIENTS
11
PubMed Central. Effect of tadalafil on blood flow, pain, and function in chronic cold Complex Regional Pain Syndrome: a randomized controlled trial